Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial crawled date : 2021 - 04 - 29 save search
Yellow Corporation to Present at 2021 Virtual Wells Fargo Industrials Conference
Published: 2021-04-29 (Crawled : 19:00) - globenewswire.com
YELL | $1.1 -29.03% -44.19% 8.1M
|
Transportation and Warehousing
|
| O: -1.36%
H: 2.23%
C: -2.55%
trial conference
Global Wireless Charging Market Report 2021: Growing Adoption of Wireless Charging in Industrial and Healthcare Applications for Continuous Power Supply
Published: 2021-04-29 (Crawled : 18:00) - prnewswire.com
QCOM | $161.45 -1.75% -1.78% 8.8M
|
Electronic Technology
|
| O: 6.18%
H: 0.2%
C: -1.61%
growing charging trial application
Landos Biopharma Announces First Patient Dosed in a Phase 1b Study of NX-13 for Ulcerative Colitis
Published: 2021-04-29 (Crawled : 18:00) - biospace.com/
LABP | $21.73 0.28% 0.28% 21K
|
|
| O: 0.0%
H: 1.03%
C: -2.64%
biopharma phase 1 phase 1b phase 2b ulcerative colitis
Peer-Reviewed Results of Haemonetics' Improving Plasma Collection (IMPACT) Trial Published in the Journal TRANSFUSION
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
HAE | $83.46 -1.67% 0.0% 970K
|
Health Technology
|
| O: 0.37%
H: 1.15%
C: -2.12%
results trial
Cara Therapeutics Announces Topline Results From KARE Phase 2 Dose-Ranging Trial of Oral KORSUVA™ in Atopic Dermatitis Patients with Moderate-to-Severe Pruritus
Published: 2021-04-29 (Crawled : 15:00) - biospace.com/
CARA | $0.69 -5.73% -6.07% 360K
|
Health Technology
|
| O: -43.48%
H: 11.0%
C: -3.47%
phase 2 results dermatitis topline trial atopic dermatitis
Compugen to Present Data Update on COM701 Phase 1 Clinical Trial at the American Society of Clinical Oncology 2021 Annual Meeting
Published: 2021-04-29 (Crawled : 14:15) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: 0.33%
H: 0.77%
C: -4.07%
phase 1 trial phase 3 phase 2
Citius Pharmaceuticals Reports Strong Clinical Community Engagement During Mino-Lok® Phase 3 Trial-Related Webinar
Published: 2021-04-29 (Crawled : 14:00) - prnewswire.com
CTXR | $0.8 -1.99% -2.02% 6.3M
|
Health Technology
|
| O: 1.07%
H: 9.49%
C: 5.98%
phase 3 trial
Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Clinical Trial of AR-15512 (TRPM8 Agonist) Ophthalmic Solution for the Treatment of Patients with Dry Eye Disease
Published: 2021-04-29 (Crawled : 14:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: -0.11%
H: 2.16%
C: -1.36%
dry eye disease treatment phase 2 eye eye disease phase 2b trial enroll
PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual Meeting
Published: 2021-04-29 (Crawled : 14:00) - biospace.com/
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: 1.0%
H: 0.81%
C: -6.24%
presentation cancer biotech iot
5G Industrial IoT Market by Component, Organization Size, Application, End-user and Region - Global Forecast to 2026
Published: 2021-04-29 (Crawled : 13:00) - prnewswire.com
KT | $12.17 0.41% 0.0% 770K
|
Communications
|
| O: 0.47%
H: 0.5%
C: 0.46%
ERIC | News | $5.065 2.74% 2.67% 29M
|
Electronic Technology
|
| O: 0.0%
H: 0.25%
C: -0.5%
5g iot trial application
AGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 Virtual Annual Meeting
Published: 2021-04-29 (Crawled : 12:00) - globenewswire.com
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 3.12%
H: 1.86%
C: 0.0%
ongoing clinical trials trial
Atea Pharmaceuticals Announces First Patient Dosed in Global Phase 3 MORNINGSKY Trial of AT-527 for Treatment of COVID-19
Published: 2021-04-29 (Crawled : 08:00) - biospace.com/
AVIR | $3.71 0.0% 270K
|
Health Technology
|
| O: 1.58%
H: 0.44%
C: -2.55%
covid treatment phase 3 trial at-527
HUTCHMED Initiates Phase II Registration Study of HMPL-689 in Patients with Follicular Lymphoma and Marginal Zone Lymphoma in China
Published: 2021-04-29 (Crawled : 08:00) - biospace.com/
HCM | $16.38 -0.43% -0.43% 190K
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -3.34%
china
WillScot Mobile Mini Holdings to Participate in the Oppenheimer Industrial Growth Conference
Published: 2021-04-29 (Crawled : 06:00) - globenewswire.com
WSC | News | $37.97 -1.89% -1.92% 2.9M
|
Finance
|
| O: 1.0%
H: 0.0%
C: -2.57%
mobile growth trial conference
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
Published: 2021-04-29 (Crawled : 01:00) - prnewswire.com
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.28%
H: 0.87%
C: 0.63%
phase 2 trial macular
New England Journal of Medicine Publishes Results of Global Phase 3 Clinical Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease
Published: 2021-04-28 (Crawled : 00:00) - biospace.com/
AKBA | $1.38 -0.72% -0.72% 2.5M
|
Health Technology
|
| O: -0.63%
H: 3.02%
C: 1.59%
disease treatment results anemia phase 3 kidney
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.